# Innate T Cells and TKI Discontinuation

> **NCT04645706** · — · ACTIVE_NOT_RECRUITING · sponsor: **Poitiers University Hospital** · enrollment: 92 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **OTHER:** Characteristics of innate T cells

## Key facts

- **NCT ID:** NCT04645706
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-20
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645706, "Innate T Cells and TKI Discontinuation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04645706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*